Netskope Q2 FY2027 Tops Guidance on AI Security Momentum

What happened

Netskope reported fiscal second-quarter 2027 results that exceeded its revenue and operating-margin guidance, underscoring resilient demand for its cloud and AI security platform. Management attributed the beat to continued platform adoption and early traction from recently introduced AI security products, with CEO Sanjay Beri emphasizing that enterprises now view security and network modernization as interconnected priorities. This positive quarterly print arrives amid a difficult tape for the stock, which has fallen over 60% from its IPO price due to post-lock-up supply overhang and persistent GAAP losses. While the beat supports the company’s growth durability narrative, it does not by itself resolve concerns over cash flow timing, dilution, or insider selling. The key question remains whether this momentum can translate into sustained ARR growth and improved free cash flow margins through the fiscal year.

Implication

Investors should treat the Q2 beat as a positive but insufficient signal to alter the risk-reward materially. The company still needs to demonstrate that the AI security traction is measurable in ARR growth and not just narrative, and that the annual billings transition does not derail the guided free cash flow margin of 2%–4% for FY2027. The stock remains vulnerable to insider selling and any slowdown in net retention below the 116% level. A more constructive stance would require either a raise in full-year guidance or clear evidence that AI module adoption is accelerating net-new ARR. Until then, existing holders may hold but new buyers should await either a lower price or stronger confirmation, with the $8–$10 range still an attractive accumulation zone only if fundamentals hold.

Thesis delta

The Q2 beat mildly strengthens the base-case thesis by confirming demand visibility and early AI product traction, but it does not move the needle on the key risks of post-IPO supply overhang and cash flow conversion. The investment thesis remains intact but unchanged: the stock is a potential buy at the low end of its range, contingent on FY2027 guidance reaffirmation and retention durability. No adjustment to conviction or price targets is warranted based solely on this news.